MALLINCKRODT FINANCE MANAGEMENT IRELAND LIMITED

Overview

Mallinckrodt Finance Management Ireland Limited is a company registered in Ireland with CRO number 572534. The name suggests a financial management role, potentially related to healthcare or pharmaceuticals, given the parent company's history in specialty therapeutics. The company is listed on Solocheck with a high name similarity match (0.90) to GoldenPages. A web scrape indicates that the parent entity, Mallinckrodt, merged with Endo in 2025, leading to the spin-off of its generics and sterile injectables business into Par Health, while the specialty therapeutics division was rebranded as Keenova Therapeutics. Keenova focuses on rare and specialized conditions across immunology, urology, hepatology, and other areas, while Par Health specializes in generics, sterile injectables, and active pharmaceutical ingredients with a global manufacturing network. The information appears to relate to a broader pharmaceutical group restructuring, not direct operations of the Irish entity. Beyond registry-level identification, no further business details are publicly captured.

Location & registered address

College Business & Technology Park

Cruiserath

Blanchardstown Dublin 15

Dublin 15

Dublin

Ireland

Industry classification

NACE Rev. 2 — 69.20 — Accounting, bookkeeping, auditing & tax consultancy

Class 69.20 covers accounting, bookkeeping and auditing activities; tax consultancy. This includes recording of commercial transactions, preparation of financial statements, auditing of accounts, tax return preparation, and tax advisory services for individuals and businesses.

→ All accounting, bookkeeping, auditing & tax consultancy companies in Ireland · In Dublin